Search research articles
Contact Us
Filters
Showing results (31-40 of 205) with videos related to
Page
of 21
Sort By:
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles
|
September 17, 1973
[Decrease of cellular immunity in hashish (marihuana) smokers]
G Nahas, N Sucui-Foca, J P Armand
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Non-randomised phase II trials of drug combinations: often meaningless, sometimes misleading. Are there alternative strategies?
M Van Glabbeke, W Steward, J P Armand
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Targeting angiogenesis with oral agents
B Besse, J-P Armand, J-C Soria
Cancer Research
|
September 1, 1984
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II)
J P Macquet, S Cros, J P Armand
Pathologie-Biologie
|
June 7, 2006
[Targeting angiogenesis in oncology]
J Fayette, J-C Soria, J-P Armand
Servir (Lisbon, Portugal)
|
March 1, 1985
[Precautions to be taken in handling anticancer drugs]
J Chauvergne, J P Armand, B N Bui
Bulletin Du Cancer
|
January 1, 1990
[Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines]
M C Malet-Martino, R Martino, J P Armand
Annals of the New York Academy of Sciences
|
December 13, 1996
CPT-11. The European experience
J P Armand, C Terret, C Couteau, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
January 1, 1980
The effect of thioproline on transplanted tumors in nude mice
J P Armand, I Neulat, C Marty, et al.
Cancer Treatment Reports
|
April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicin
P Hurteloup, P Cappelaere, J P Armand, et al.
Page
of 21
Search research articles
Search
Showing results (31-40 of 205) with videos related to
Sort By:
Page
of 21
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles
|
September 17, 1973
[Decrease of cellular immunity in hashish (marihuana) smokers]
G Nahas, N Sucui-Foca, J P Armand
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Non-randomised phase II trials of drug combinations: often meaningless, sometimes misleading. Are there alternative strategies?
M Van Glabbeke, W Steward, J P Armand
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Targeting angiogenesis with oral agents
B Besse, J-P Armand, J-C Soria
Cancer Research
|
September 1, 1984
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II)
J P Macquet, S Cros, J P Armand
Pathologie-Biologie
|
June 7, 2006
[Targeting angiogenesis in oncology]
J Fayette, J-C Soria, J-P Armand
Servir (Lisbon, Portugal)
|
March 1, 1985
[Precautions to be taken in handling anticancer drugs]
J Chauvergne, J P Armand, B N Bui
Bulletin Du Cancer
|
January 1, 1990
[Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines]
M C Malet-Martino, R Martino, J P Armand
Annals of the New York Academy of Sciences
|
December 13, 1996
CPT-11. The European experience
J P Armand, C Terret, C Couteau, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
January 1, 1980
The effect of thioproline on transplanted tumors in nude mice
J P Armand, I Neulat, C Marty, et al.
Cancer Treatment Reports
|
April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicin
P Hurteloup, P Cappelaere, J P Armand, et al.
Page
of 21